FUSN NASDAQ
Fusion Pharmaceuticals Inc.
1W: +0.5%
1M: +0.5%
3M: +105.2%
1Y: +339.8%
3Y: +164.4%
$21.55
Last traded 2024-06-04 — delisted
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$286M
+30.5% ▲
5Y CAGR: +55.5%
Total Liabilities
$63M
+11.5% ▲
5Y CAGR: +5.1%
Shareholders Equity
$222M
+37.1% ▲
Cash & Investments
$234M
+25.4% ▲
5Y CAGR: +52.1%
Total Debt
$50M
+25.0% ▲
Net Debt
-$12M
-221.3% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $65M | $91M | $53M | $44M | $62M |
| Short-Term Investments | $0 | $132M | $148M | $127M | $172M |
| Cash & ST Investments | $65M | $222M | $201M | $187M | $234M |
| Net Receivables | $428K | $794K | $357K | $2M | $4M |
| Inventory | $503K | $4M | $0 | -$10M | $0 |
| Other Current Assets | $278K | $727K | $233K | $509K | $5M |
| Total Current Assets | $67M | $228M | $212M | $179M | $243M |
| Property, Plant & Equip. | $1M | $2M | $9M | $10M | $24M |
| Goodwill & Intangibles | -$1M | $0 | $0 | $0 | -$849K |
| Long-Term Investments | $1M | $77M | $20M | $16M | $15M |
| Other Non-Current Assets | $1M | $3M | $9M | $9M | $849K |
| Total Non-Current Assets | $3M | $83M | $41M | $40M | $42M |
| Total Assets | $69M | $311M | $252M | $219M | $286M |
| — Liabilities — | |||||
| Accounts Payable | $830K | $3M | $2M | $3M | $2M |
| Short-Term Debt | $0 | $0 | $1M | $1M | $4M |
| Deferred Revenue | $0 | $1M | $2M | $924K | $333K |
| Other Current Liabilities | $3M | $7M | $8M | $10M | $10M |
| Total Current Liabilities | $4M | $12M | $13M | $15M | $16M |
| Long-Term Debt | $6M | $0 | $6M | $39M | $35M |
| Other Non-Current Liab. | $93M | $306K | $297K | $299K | $301K |
| Total Non-Current Liabilities | $99M | $4M | $8M | $42M | $47M |
| Total Liabilities | $103M | $16M | $21M | $57M | $63M |
| — Equity — | |||||
| Common Stock | $0 | $0 | $0 | $0 | $0 |
| Retained Earnings | -$35M | -$113M | -$194M | -$282M | -$377M |
| Accumulated OCI | $0 | $44K | -$115K | -$469K | $237K |
| Total Stockholders Equity | -$33M | $295M | $231M | $162M | $222M |
| Total Liabilities & Equity | $69M | $311M | $252M | $219M | $286M |
| — Key Metrics — | |||||
| Total Debt | $6M | $0 | $7M | $40M | $50M |
| Net Debt | -$60M | -$91M | -$46M | -$4M | -$12M |
| Total Investments | $1M | $209M | $168M | $143M | $187M |